Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 03 2021
Historique:
pubmed: 9 1 2021
medline: 23 3 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

Exosomes are an important mechanism of cell-cell interaction in the cardiovascular system, both in maintaining homeostasis and in stress response. Interindividual differences that alter content in exosomes may play a role in cardiovascular disease pathology. To study the effect of interindividual cardiomyocyte (CM) variation, we characterized exosomal content in phenotypically diverse human induced pluripotent stem cell-derived CMs (hiPSC-CMs). Cell lines were generated from six participants in the HyperGEN cohort: three with left ventricular hypertrophy (LVH) and three with normal left ventricular mass (LVM). Sequence analysis of the intracellular and exosomal RNA populations showed distinct expression pattern differences between hiPSC-CM lines derived from individuals with LVH and those with normal LVM. Functional analysis of hiPSC-endothelial cells (hiPSC-ECs) treated with exosomes from both hiPSC-CM groups showed significant variation in response, including differences in tube formation, migration, and proliferation. Overall, treatment of hiPSC-ECs with exosomes resulted in significant expression changes associated with angiogenesis and endothelial cell vasculogenesis. However, the hiPSC-ECs treated with exosomes from the LVH-affected donors exhibited significantly increased proliferation but decreased tube formation and migration, suggesting angiogenic dysregulation.

Identifiants

pubmed: 33416449
doi: 10.1152/ajpheart.00463.2020
pmc: PMC8294700
doi:

Substances chimiques

MicroRNAs 0
RNA, Messenger 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

H954-H968

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL055673
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL125580
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01HL107437
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL055673
Pays : United States

Références

Cardiovasc Res. 2014 May 1;102(2):249-57
pubmed: 24591150
Nat Rev Cardiol. 2017 Apr;14(4):238-250
pubmed: 28004807
Neth Heart J. 2013 Jul;21(7-8):367-71
pubmed: 23864481
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Stem Cells. 2017 Apr;35(4):851-858
pubmed: 28294454
Cardiovasc Res. 2006 Jul 15;71(2):342-51
pubmed: 16698001
Mol Cancer. 2019 Dec 10;18(1):181
pubmed: 31823788
Circ Res. 2017 Jan 20;120(2):407-417
pubmed: 28104773
J Clin Invest. 2007 Nov;117(11):3176-9
pubmed: 17975662
Vascul Pharmacol. 2015 Aug;71:24-30
pubmed: 25869502
Stem Cell Res Ther. 2015 Apr 10;6:10
pubmed: 26268554
J Clin Invest. 2017 Apr 3;127(4):1375-1391
pubmed: 28319051
J Am Heart Assoc. 2015 Feb 24;4(2):
pubmed: 25713289
Circulation. 2018 Apr 17;137(16):1712-1730
pubmed: 29233823
Elife. 2020 Jan 24;9:
pubmed: 31976858
Stem Cells. 2009 Jan;27(1):230-7
pubmed: 18772313
Circ Res. 2015 Jun 19;117(1):89-98
pubmed: 26089366
Cardiovasc Res. 2017 Sep 1;113(11):1338-1350
pubmed: 28859292
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
Science. 2009 May 8;324(5928):797-801
pubmed: 19325077
Genome Biol. 2014;15(12):550
pubmed: 25516281
FASEB J. 2010 Sep;24(9):3186-95
pubmed: 20400538
Heart Fail Rev. 2013 Sep;18(5):607-22
pubmed: 22948484
Cell Cycle. 2006 Mar;5(5):512-8
pubmed: 16552185
Circ Res. 2013 Feb 1;112(3):523-33
pubmed: 23371901
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Nature. 2016 Oct 20;538(7625):388-391
pubmed: 27723741
Clin Cardiol. 1993 May;16(5 Suppl 2):II10-4
pubmed: 8504584
Circ Heart Fail. 2016 Apr;9(4):e002760
pubmed: 27056881
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Stem Cell Reports. 2014 May 08;2(5):606-19
pubmed: 24936449
Stem Cells Transl Med. 2017 Jan;6(1):209-222
pubmed: 28170197
Front Physiol. 2016 Mar 18;7:98
pubmed: 27047385
Nat Biomed Eng. 2018 May;2(5):293-303
pubmed: 30271672
Cytotherapy. 2018 Mar;20(3):291-301
pubmed: 29434006
J Cell Sci. 2015 Oct 1;128(19):3556-68
pubmed: 26136364
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
J Cell Mol Med. 2018 Oct;22(10):4568-4587
pubmed: 29956461
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Int J Cardiol. 2015 Aug 1;192:61-9
pubmed: 26000464
Mol Ther. 2018 Jul 5;26(7):1624-1634
pubmed: 29699941
J Biol Chem. 2002 Jul 5;277(27):24453-9
pubmed: 11983702
Physiol Genomics. 2018 Feb 1;50(2):77-97
pubmed: 29187515
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Exp Mol Med. 2019 Nov 13;51(11):1-11
pubmed: 31723119
Circulation. 2015 Mar 17;131(11):1019-30
pubmed: 25779542
Circ Res. 2014 Jan 31;114(3):565-71
pubmed: 24481846
J Cardiovasc Transl Res. 2010 Aug;3(4):330-43
pubmed: 20559774
Sci Rep. 2016 Jan 14;6:19464
pubmed: 26763872
Oxid Med Cell Longev. 2014;2014:260429
pubmed: 25101151
Development. 2012 Dec 1;139(23):4356-64
pubmed: 23132244
Lab Chip. 2020 Mar 17;20(6):1153-1166
pubmed: 32100769
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):211-7
pubmed: 12588761
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2006-17
pubmed: 21890694
Circulation. 2010 Aug 31;122(9):928-37
pubmed: 20805439
Int J Obes (Lond). 2016 Jan;40(1):102-11
pubmed: 26122028
J Clin Invest. 2019 Apr 29;129(6):2237-2250
pubmed: 31033484
Cell Signal. 2017 Jan;29:84-95
pubmed: 27742560
Theranostics. 2017 Jan 26;7(3):789-804
pubmed: 28255367
Eur Heart J. 2017 Jan 14;38(3):201-211
pubmed: 28158410
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
J Transl Med. 2019 Mar 11;17(1):75
pubmed: 30871557
Nat Biotechnol. 2018 Aug;36(7):597-605
pubmed: 29969440
Front Mol Neurosci. 2011 Dec 02;4:51
pubmed: 22144946

Auteurs

Amy Turner (A)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Praful Aggarwal (P)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Andrea Matter (A)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Benjamin Olson (B)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Department of Molecular Genetics and Genomics, Washington University, St. Louis, Missouri.

C Charles Gu (CC)

Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri.

Steven C Hunt (SC)

Department of Genetic Medicine, Weill Cornell Medicine, Doha, Qatar.
Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah.

Cora E Lewis (CE)

Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Donna K Arnett (DK)

Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, Kentucky.

Rachel Lorier (R)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Ulrich Broeckel (U)

Section of Genomic Pediatrics, Department of Pediatrics, Medicine and Physiology, Children's Research Institute and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH